Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study

An experimental Parkinson’s drug missed its main purpose in a mid-stage trial, Roche stated, in what’s the second setback this week for candidate remedies for the neurodegenerative situation.



Source link